Featured Post

Orphans and the world at large

Losing a parent is undoubtedly a traumatic experience for any child. It is an experience that will follow that child, likely playing a larg...

Monday, March 21, 2016

Staying updated

Notable  research information from Dr. Amita Gupta , MD , Johns Hopkins Bloomberg School of Public Health.

Death in the early months following initiation of antiretroviral treatment is common among patients with advanced HIV living in resource-limited countries with a high prevalence of HIV.
Despite the success of antiretroviral programs in these resource-limited areas, many patients still present for treatment with advanced HIV disease and up to 17% of adults die in the first year of antiviral therapy, the researchers wrote.


"One of the biggest drivers of morbidity and mortality in this setting is tuberculosis,"
He noted that up to 70% of patients with tuberculosis living in sub-Saharan Africa are HIV positive.
 "Patients with HIV may not have commonly recognized symptoms of tuberculosis, which complicates diagnosis," he said.

Visit us often to see your donations at work

Followers